Despite serious efforts deployed at national and European level, the European Union sees significant internal disparities in terms of research and innovation performance. There is significant evidence pointing to the fact that the pathway to economic growth and competitiveness is strongly connected to the scaling up of investment in research and innovation.
In order to reduce the research and innovation gap, Horizon 2020 introduces specific measures for spreading excellence and widening participation. These measures are targeted at low-performing Member States in terms of research and innovation.
Widening consists of three main actions, i.e. Teaming, Twinning and ERA Chairs, for which specific eligibility conditions apply. This ensures a targeted approach towards Widening Member States and Associated Countries.
The Widening member states are: Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovakia and Slovenia.
Belgium is not identified as a Widening Member State but can partake as partner.
manhei.to@fwo.be
+32 2 550 15 55
Infosheets contain edited content on aspects related to this programme. They are reviewed at least yearly.
Related links are easy pointers towards external information. We curate the list, but are not liable for the destinations.
Documents contain additional information related to this programme, and are similar to related links.
The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities.
The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.